Clinical trial

Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler

NCT02980133

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Fluticasone Propionate Normalized identity: fluticasone propionateView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Fluticasone Propionate/Salmeterol Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo MDPI Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-12-28

PhasePHASE3

Conditions

Asthmaverified · MONDO: asthma

Interventions

Fluticasone PropionateDRUG · verified · RxNorm: fluticasone propionate

Fluticasone Propionate/SalmeterolDRUG

Placebo MDPIDRUG

Sponsors & collaborators

Teva Branded Pharmaceutical Products R&D, Inc.lead sponsor

Mapped research locations

MiamiFlorida, United States7 Saint PetersburgRussia6 San AntonioTexas, United States3 Oklahoma CityOklahoma, United States3 BudapestHungary3 KyivUkraine3 CharlestonSouth Carolina, United States2 TulsaOklahoma, United States2 ColumbiaMissouri, United States2 Huntington BeachCalifornia, United States2 OdesaUkraine2 PittsburghPennsylvania, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02980133 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.